Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Flow Cytometry In Oncology And Immunology Market from 2024 to 2025?

The market size of flow cytometry in oncology and immunology has seen rapid expansion in the recent past. It will see a rise from $2.11 billion in 2024 to $2.33 billion in 2025, registering a compound annual growth rate (CAGR) of 10.4%. The historic expansion can be tied to advancements in cancer and immunology research, diagnostic application developments, an increase in autoimmune diseases, advancements in drug development and clinical trials.

What Is the Projected Market Size of the Flow Cytometry In Oncology And Immunology Market?

The cytometry in oncology and immunology sector is predicted to expand rapidly in the upcoming years, with a potential growth to $3.46 billion by 2029 due to a compound annual growth rate (CAGR) of 10.4%. The projected growth during the forecast period can be linked to its integration with genomics and proteomics, the increasing usage of single-cell analysis, the broadening application range in infectious diseases, increased cancer occurrences, and the rise of point-of-care flow cytometry. Key trends for the forecast period encompass immunophenotyping for immunotherapy, miniaturizing flow cytometry systems, multiparametric analysis, a shift towards spectral flow cytometry, and cooperative research initiatives.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp

Who are the Major Competitors in the Flow Cytometry In Oncology And Immunology Market Outlook?

Major companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason

What Is Fueling Growth in the Flow Cytometry In Oncology And Immunology Market?

The escalation in cancer cases is projected to fuel the expansion of flow cytometry in the fields of oncology and immunology. Cancer, a disease identified by the uncontrolled multiplication and dissemination of abnormal cells within the body, employs flow cytometry extensively. This technique is frequently utilized in oncology and immunology to study cancer and immune cells. For example, Macmillan Cancer Support, a health charity based in the UK, reported that in 2020, there were 3 million cases of cancer. They project that this figure will escalate to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the surge in cancer cases is propelling the demand for flow cytometry in the oncology and immunology markets.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12469&type=smp

Which Flow Cytometry In Oncology And Immunology Market Segments Are Growing the Fastest?

The flow cytometry in oncology and immunology market covered in this report is segmented –

1) By Type: Immunology, Oncology

2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry

3) By Application: Translational Research, Clinical Research

4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users

Subsegments:

1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing

2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation

Which Industry Trends Are Shaping the Future of the Flow Cytometry In Oncology And Immunology Market?

Technological progress is emerging as an influential trend in the flow cytometry sector, specifically within the oncology and immunology market. Large-scale businesses active in these markets are embracing new technologies to maintain their market lead. Example being, Becton Dickinson and Company, a US-based medical technology firm, unveiled the BD Research Cloud for flow cytometry in oncology and immunology in September 2022. This cloud-based software solution simplifies the flow cytometry procedure for researchers operating in diverse domains such as immunology, virology, infectious disease, and oncology surveillance, thereby facilitating superior quality research with faster insights. BD is utilizing cutting-edge technologies like BD Horizon RealYellow and RealBlue Reagents, along with the newly debuted BD FACSDiscover S8 Cell Sorter with BD CellView Image Technology, to boost flow cytometry abilities, helping researchers to refine and boost their innovative studies. Being developed on a standard cloud infrastructure, BD Research Cloud is especially designed for BD equipment and reagents.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Which Countries Are Leading the Flow Cytometry In Oncology And Immunology Market?

North America was the largest region in the flow cytometry in oncology and immunology market in 2024. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12469

This Report Delivers Insight On:

1. How big is the flow cytometry in oncology and immunology market, and how is it changing globally?

2. Who are the major companies in the flow cytometry in oncology and immunology market, and how are they performing?

3. What are the key opportunities and risks in the flow cytometry in oncology and immunology market right now?

4. Which products or customer segments are growing the most in the flow cytometry in oncology and immunology market?

5. What factors are helping or slowing down the growth of the flow cytometry in oncology and immunology market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model